Sponsored by Inovalon
Apr 2024
Join Inovalon’s experts as they discuss the power of combining RCT with real-world data, through innovative data-linking techniques, to transform understanding of the patient journey to uncover invaluable insights into clinical and economic outcomes in the real-world.
Feb 2023
The workshop will use real-time polling to understand the audience’s experiences with data collection fraud online and the methods used to prevent and identify data collection fraud. We will encourage audience members to share their own strategies, learnings, and challenges.
Jan 2023
An ageing population means an urgent need for better and effective treatment for age-related illnesses. Despite billion-dollar investments for drug development for these conditions, especially neurogenerative diseases, there is a low success rate and it is a slow process.
Sponsored by Evidera, a PPD Company
Oct 2022
This webinar will explore what the SUCRA is, demonstrate how it can be meaningfully impacted by network composition (even in simple networks), and suggest corrections to common errors in the reporting of SUCRAs.
Sep 2022
Asia Pacific regional markets, including but not limited to mainland China, Japan, South Korea and Taiwan, play increasingly important roles in global clinical development. Patient-centric endpoints via clinical outcome assessments (COAs) and electronic COAs (eCOAs), are getting more and more attention in clinical research design and execution.
Sponsored by AstraZeneca
Jun 2022
For cancer drugs, payers often prefer to make decisions based on overall survival (OS) outcomes. However, it may take many years to collect OS data; this is particularly apparent in early-stage cancer and when an active therapy is highly effective at extending life.
Sponsored by MDClone
May 2022
Real-world evidence has advanced health research over the past two or three decades. The challenges of procuring sufficient, high-quality real-world data, of unlocking the knowledge contained in the data, and of sharing information without compromising patient privacy are ever-present.
Apr 2022
Speakers will discuss the many uses of COA data gathered during patient-focused drug development, including benefit/risk evaluation, HTA, access decisions, policy decisions, and clinician and patient decision-making.
Apr 2022
The key success factor for digital health implementation is the information sharing across multiple stakeholders engaged in the clinical decision making. The COVID pandemic revealed numerous differences in how individual data are used in the process of the adoption of various digital health solutions in the healthcare systems across the globe.
Sponsored by Medtronic
Mar 2022
Experts from around the world will be sharing their experience about obesity treatment and reimbursement policies in their different countries. The event will consist of 7 expert presentations followed by a round table discussion with an opportunity for the audience to ask questions.
Jan 2022
This webinar will be useful for researchers, regulators, academics, industry sponsors, and instrument developers in the clinical outcomes assessment (COA) field working on the development, evaluation, and implementation of performance outcome (PerfO) measures for use in capturing clinical benefits in treatment trials for medical label claims.
Sponsored by Syneos Health
Sep 2021
In this webinar, experts will explore embedded clinical trials and their potential for effectively generating real world evidence, and review case studies illustrating best practice for these trials in action.
Sponsored by Certara
Sep 2021
Securing reimbursement from national payers is critical to your product’s commercial success. However, payers at the local and regional levels continue to get more authority to manage their own budgets. This makes engaging with payers and designing an effective strategy for value communication difficult as the concept of value can mean different things to different stakeholders.
Sponsored by Ontada
Aug 2021
They will address challenges faced by the pharmaceutical industry with clinical trials and the potential benefits that may be addressed with external controls, including lower costs, increased efficiency, time savings and potential ways to introduce real-world data elements for regulatory decisions.
Dec 2014